Table 1.
HEV prevalence in blood donors
| Country | Method | Samples | Results | References |
|---|---|---|---|---|
| Ghana | Individual testing | 239 | 0/239 | Meldal et al. 2013 |
| United States | Individual testing | 1939 | 0/1939 | Xu et al. 2013 |
| Canada | Pools of 48/100 | 13.993 | 0/13.993 | Fearon et al. 2017 |
| Australia | Pools of 6 | 74.131 | 1/74.131 | Hoad et al. 2017 |
| United States | Pools of 96 | 128.020 | 1/32.005 | Roth et al. 2017 |
| United States | Individual testing | 18.829 | 1/9500 | Stramer 2014 |
| Germany | Pools of 96 | 18.100 | 1/4525 | Baylis et al. 2012 |
| Spain | Individual testing | 9.998 | 1/3333 | Sauleda et al. 2014 |
| United Kingdom | Pools of 24 | 225.000 | 1/2850 | Hewitt et al. 2014 |
| France | Pools of 96 | 53.234 | 1/2218 | Gallian et al. 2014 |
| The Netherlands | Pools of 96/192 | 59.474 | 1/1440 | Hogema et al. 2016 |
| Germany | Pools of 48 | 16.000 | 1/1250 | Vollmer et al. 2012 |